ALC Health has entered into a ‘reverse branch’ agreement with London Global srl., an Italian company regulated and based in Italy, with a branch in the UK. As a result of this agreement, London Global have oversight of ALC Health’s operation and some of ALC Health’s staff have been seconded to London Global. Post Brexit, this agreement allows ALC Health to continue to offer its products in the UK and in EU member countries and where those products are sold by intermediaries (where those brokers have the relevant permissions to operate). Day-to-day operations are unaffected, the products will still work in the same way , you will still deal with the same friendly and efficient team . Products will continue to be underwritten by XL Catlin Insurance Company UK Limited for policies sold to UK residents and XL Insurance Company SE for persons residing in the EU.
International Medical Group® (IMG®) is pleased to announce that their global family of brands, including ALC Health, iTravelInsured, AkesoCare, and Global Response, will all be unified under the IMG brand. Read the full announcement.
We have launched a unique new product for pilots and air crew called ‘Flying Colours’. This offers MHD terms to individual
applicants at discounted premiums.
Our CEO, Sarah Jewell, was recently interviewed about the new product in ‘Global Health Insider’ magazine. Click HERE to read the interview in full and find out more about this exciting and
To obtain a quote for ‘Flying Colours’, please contact our sales team at email@example.com or by phone +44 (0)1903 817970
For more information visit our dedicated web page
If you have ever lived in the UK, USA or Germany, there is a high chance you know this slogan very well. But what does it exactly mean? Why 5? Is there any truth to this?
The ‘5-a-day’ campaign was introduced in 2003 by the UK Department of Health as the minimum daily consumption of fruits and vegetables. Since then, its popularity skyrocketed and it’s now even the basis of the School Fruit and Vegetable Scheme in the UK. The food guide ‘Balance of Good Health’ also supports this campaign as it fits with the recommendations of 425 g intake of fruits and vegetables per day.
But why do we need fruits and vegetables?
The most eye-opening truth behind this campaign is that most people fail to reach their minimum 5-a-day balanced intake of fruit and vegetables. A 2013 study showed that adults in the USA consume fruit 1.1 times per day and vegetables 1.6 times per day. Not consuming enough fruit and vegetables can result in serious vitamin and mineral deficiencies, digestive issues, disease risks, cardiovascular health problems and weight gain.
There are several beneficial reasons behind this campaign and the first has to do with decreasing risk of diseases, such as diabetes, heart diseases and obesity. The UCL studyalso reports that eating seven or more portions of fruit and vegetables a day reduces a risk of early death by 42%.
Eating enough fruit and vegetables also ensures your body remains healthy and energized throughout the day as they contain a heavy dose of vitamins and minerals.
As most fruit and veggies are quite low in calories, you won’t need to feel guilty for eating a few more than you’re supposed to.
“When it comes to fruit and vegetables, as long as you watch your calorie and sugar intake it is very much the case of the more the merrier” state the NHS.
Your “5 a day” around the world
- The Netherlands – 2 ounces of vegetables and 2 pieces of fruit
- Germany – 3 vegetables (400 g total) and 2 pieces of fruit (250 g total)
- Slovakia – minimum of 400 g fruit and vegetables
- Austria – 5 servings of fruit and vegetables, or ≥400 g
- Finland – 400 g fruit and vegetables, revised to 500 g from the 23rd Jan 2014
- Ireland – 5-7 servings of fruit and vegetables
- Brazil – 3 portions of fruit, 3 of vegetables/legumes, and 1 of beans
- Australia – 5-6 x 75 g servings of vegetables, 2 x 150 g fruit
SOURE : Expathealth.org
According to a study conducted by the Consumer Reports on the effect of caramel colouring used in soft drinks, the daily consumption of fizzy drinks is more dangerous than we thought.
The laboratory tests on 11 different soft drinks revealed that one can a day could be enough to expose a consumer to potentially cancer-causing levels of the chemical 4-MeI, which is short for 4-methylimidazole. Surprisingly however, the levels of 4-MeI varied in samples of the same type of fizzy drinks. Tyler Smith, the lead author of the Johns Hopkins study, the team that led the Consumer Reports researchers, said that “For example, in diet drinks, certain samples had higher or more variable levels of the compound, while other samples had very low concentrations”.
SOURCE | Expathealth.org
The trend – as parents try to give their children an auspicious start in life or to avoid being stuck in hospital during the holidays – has prompted insurance companies to double their fees or even halt some maternity policies.
Tradition dictates, according to some fortune tellers, that babies born in the Year of the Horse are more vigorous than those born in the Year of the Goat, which begins on Thursday. Well-known Hong Kong fortune teller Mak Ling-ling said some parents were keen to have their babies early in order for their “luckier” offspring to collect lai see – cash gifts given over Lunar New Year – from their relatives. READ MORE HERE >
Experts believe that a simple breath test could help doctors detect and diagnose Parkinson’s disease.
The test looks for a unique signature of chemicals in exhaled breath.
Small studies in volunteers have begun and early findings suggest the test can identify those with the debilitating brain condition.
Larger trials are now planned to see if it could truly be a useful test, particularly for picking up Parkinson’s in its earliest stages.
Currently, no test can conclusively show that a person has Parkinson’s.
Instead, doctors reach a diagnosis based on a person’s symptoms and test results – such as brain scans to rule out other diseases.
At this stage, Parkinson’s may already be fairly advanced.
Identifying it earlier would be beneficial because it would mean treatment could be given sooner.
Parkinson’s disease is a progressive condition where there is gradual loss of nerve cells from the brain.
And it is thought that this degradation leaves a chemical footprint in the body that could potentially be used in diagnostic tests.
Scientists have been exploring different ways of finding such biomarkers, including looking in blood, spinal fluid, and exhaled breath.
The breath test looks for traces of volatile organic compounds or VOCs in the air we exhale.
In a small trial in Israel with 57 people, some with Parkinson’s and some without, the test could identify the individuals with Parkinson’s by looking for distinctive patterns of VOCs.
It also appeared to distinguish between different sub-types of the disease based on the presence and quantity of different VOCs.
The charity Parkinson’s UK and experts at the University of Cambridge were intrigued by these early findings and are now setting out to do a bigger study involving 200 volunteers from England.
Dr Simon Stott, who is part of this UK team and will be working alongside the scientists from the Israel Institute of Technology, in Haifa, said: “We would like to find biomarkers that can identify patients early.
“A breath test would be really appealing because it’s non-invasive, non-painful and can be done in seconds.
“While it wouldn’t replace what doctors already do, it could be a useful diagnostic tool to help them.”
The biggest hope is that there may be molecules in the breath of people with Parkinson’s which throw up new options for drug targets.
The researchers say they have many years of work ahead of them before they will know if the test can be used in clinics.
Frequent eye movements in babies could be a clue to whether they will develop an autism spectrum disorder, a Medical Research Council study suggests.
Using eye-tracking technology, researchers measured 100 six-month-old babies looking at a static image.
Those later diagnosed with ASD moved their eyes around more often, which could be a cause of learning problems.
Women with type 1 diabetes face a greater risk of dying from a range of diseases compared with men with the same condition, research suggests.
This is particularly the case when it comes to heart disease, Australian scientists report.
They say their findings could have “profound implications” for how women with the condition are treated.
Charities warn that the study highlights a failure of care that needs to be changed urgently.
Type 1 diabetes is a disorder that often appears in childhood. Patients’ pancreases are unable to produce the insulin needed to convert sugar and other foods into energy.
Compared with the general population, people with type 1 diabetes have a shorter life expectancy. But researchers say it hasn’t been clear until now whether this affects men and women equally.
To investigate this, scientists from the University of Queensland analysed data from more than 26 studies involving some 200,000 people with the disease.
Overall, they found women had a 40% increased risk of deaths from all causes.
They faced a greater risk of stroke than men and were also more likely to die from kidney disease.
No-one is entirely sure what lies behind these trends.
Simon O’Neill, of Diabetes UK said there had been evidence to suggest changes to girls’ bodies during puberty could make it more difficult for them to get their diabetes under control.
He added: “We need the NHS to urgently improve diabetes care so that all people are offered care that is tailored to their individual needs and so are able to manage their condition effectively and reduce their risk of devastating complications and early death.
“With the right care and support in place there is no reason why people with type 1 diabetes – both men and women – can’t live long, healthy lives.”
Sarah Johnson, from type 1 diabetes charity JDRF, said: “I’m angry. These findings show that type 1 diabetes care is failing and these failings should be addressed urgently for everyone with the condition – not just women.”
Prof Rachel Huxley, lead researcher on the project, said in a statement: “The marked difference between the sexes for vascular-related disease is likely to have profound clinical implications for how women with type 1 diabetes are treated and managed throughout their lives.”
The study appears in the journal Lancet Diabetes and Endocrinology.